Association of semaglutide with less limb events in people with type 2 diabetes and peripheral artery disease or foot ulcers: An observational study comparing matched cohorts

Ähnliche Einträge

• Liraglutide improves peripheral perfusion and markers of angiogenesis and inflammation in people with type 2 diabetes and peripheral artery disease: An 18‐month follow‐up of a randomized clinical trial
  von: Paola Caruso, et al.
  Veröffentlicht: (2025)
• Glucagon‐like peptide 1 receptor agonist for peripheral artery disease: Is it time to proceed?
  von: Dario Giugliano, et al.
  Veröffentlicht: (2025)
• Two years with GIOIA ‘Effects of gliflozins and gliptins on markers of cardiovascular damage in type 2 diabetes’: A prospective, multicentre, quasi‐experimental study on sodium‐glucose cotransporter 2 and dipeptidyl peptidase‐4 inhibitors in diabetes clinical practice
  von: Miriam Longo, et al.
  Veröffentlicht: (2024)
• Exploring Insulin Resistance in Adults With Type 1 Diabetes: The Role of the Estimated Glucose Disposal Rate and the Triglyceride Glucose Index
  von: Silvia Angelino, et al.
  Veröffentlicht: (2025)
• Islet Autoantibodies in Adult With Pituitary and Ovarian Autoimmunity: Implications for Type 1 Diabetes Screening
  von: Giuseppe Bellastella, et al.
  Veröffentlicht: (2026)